A cross-sectional hospital-based study of autoantibody profile and clinical manifestations of systemic lupus erythematosus in south Indian patients

Indian Journal of Medical Microbiology

Volumn 28, Issue 3, 2010, Pages 245-247

  Kosaraju, K ^a   Shenoy, S ^a   Suchithra, U ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

ANA profile; anti dsDNA; antinuclear antibodies; systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; AUTOANTIBODY;

ABORTION; ADOLESCENT; ADULT; AGED; ALOPECIA; ARTHRITIS; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FEVER; HEMATURIA; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INDIA; KIDNEY DISEASE; LUNG DISEASE; MALE; MENSTRUAL IRREGULARITY; MOUTH ULCER; PAROTID GLAND DISEASE; PHOTOSENSITIVITY; PROTEINURIA; RASH; SCHOOL CHILD; SEIZURE; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBERCULOSIS; ULCER; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; EXANTHEMA; FLUORESCENT ANTIBODY TECHNIQUE; HOSPITAL; MIDDLE AGED; NEPHRITIS; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ARTHRITIS; AUTOANTIBODIES; CHILD; CROSS-SECTIONAL STUDIES; EXANTHEMA; FEMALE; FEVER; FLUORESCENT ANTIBODY TECHNIQUE; HOSPITALS; HUMANS; IMMUNOBLOTTING; INDIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NEPHRITIS; YOUNG ADULT;

EID: 77955115601     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.66487     Document Type: Article

References (15)

1. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003;56:481-490
2. Kumar A, Gupta R, Aneja R, Grover R, Vijayaraghavan M, Sharma S. A 43yr old lady with SLE and nephritic syndrome. Indian J Rheumatol 2006;1:29-35.
3. Manolios N, Schrieber L. Systemic lupus erythematosus. In: Bradley J, McCluskey J, editors. Clinical Immunology. Philadelphia: Oxford Medical Publications; 1997. p. 329-345
4. Ghosh P, Dwivedi S, Naik S, Agarwal V, Verma A, Aggarwal A, et al. ANA by indirect IF: optimum screening dilution for diagnosis of SLE. Indian J Med Res 2007;26:34-38
5. Aggarwal A, Kumar A, Wanchu A, Madhavan R. Utilisation and interpretation of immunological tests. J Indian Rheumatol Assoc 2003;11:19-21.
6. Paul BJ, Farsaludeen M, Kumar N, Razia MV. Clinical profile of SLE in Northern Kerala. J Indian Rheumatol Assoc 2003;11:94-97
7. Akrekar SM, Bichile LS, Kale V. Cutaneous vasculitis in lupus: A turning point in the history of disease? A case report and review of literature. J Indian Rheumatol Assoc 2005;13:29-31.
8. Kumar A. Indian guidelines on the management of SLE. J India Rheumatol Assoc 2002;10:80-96.
9. Malaviya AN, Singh RR, Kumar A, De A, Kumar A, Aradhye S. SLE - in Northern India. A review of 329 cases. J Assoc Physicians India 1988;36:476-480
10. Vaidya S, Samant RS, Nadkar MY, Borges NE. SLE - Review of 220 patients. J Indian Rheumat Assoc 1997;5:14-18
11. Kim HA, Chung JW, Park HJ, Joe DY, Yim HE, Park HS, et al. An Antinuclear antibody negative patient with lupus nephritis. Korean J Intern Med 2009;24:76-79
12. Isenberg DA, Manson JJ, Ehrenstein MR, Rahman A. Fifty years of anti-dsDNA antibodies: are we approaching journey's end? Rheumatology (Oxford) 2007;46:1052-1056
13. Kurata N, Hara I. Immunopathological study on lupus nephritis. Jpn J Med 1980;19:245-247
14. Almehed K, d'Elia HF, Bokarewa M, Carlsten H. Role of resistin as a marker of inflammation in SLE. Arthritis Res Ther 2008;10:R15.
15. Alba P, Bento L, Cuadrado MJ, Karim Y, Tungekar MF, Abbs I, et al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis 2003;62:556-560